irinotecan, carboplatin, and sunitinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for irinotecan, carboplatin, and sunitinib, covering 2013-02-15 to 2013-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer [Phase 2]